Aaron Diaz

University of California, San Francisco
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Purpose: Pediatric recurrent medulloblastoma and atypical teratoid/rhabdoid tumor (ATRT) are largely incurable and warrant novel therapies. PNOC005 is a phase I clinical trial investigating the safety and tolerability of intratumoral or intrathecal administration of oncolytic measles virus (MV-NIS) in children and young adults with recurrent medulloblastoma or ATRT. Patients and Methods: We investigated (i) the safety of a measles virus variant, MV-NIS, in a pediatric phase I study and (ii) the mechanisms of MV-NIS and the potential benefit of combination with immune checkpoint inhibition (ICI). Pediatric patients with recurrent medulloblastoma or ATRT were treated with intratumoral injections for local recurrence or via lumbar puncture for disseminated recurrence. We evaluated local immune responses to MV-NIS with and without ICI via single-cell and bulk RNA sequencing in an intracranial, immunocompetent, syngeneic murine model. Results: MV-NIS given intratumorally or via repeat intrathecal dosing was safe. MV-NIS prolonged survival in murine models but did not demonstrate an additive benefit with ICI. No changes in tumor-infiltrating immune cell composition or activation were observed in response to MV-NIS treatment; however, MV-NIS induced local expression of neutralizing antibodies, complement cascade, and phagocytosis-related genes. Conclusions: This is the first trial investigating intratumoral as well as repeated intrathecal delivery of MV-NIS in children with medulloblastoma and ATRT. We show that the therapy is safe and well tolerated, with minimal adverse effects. Immune markers and biological correlates preliminarily indicate antiviral effects in tumors.

Year:

2025

Glioblastoma (GBM) is an immunologically “cold” tumor that does not respond to current immunotherapy. Here, we demonstrate a fundamental role for the α-isoform of the catalytic subunit of protein phosphatase-2A (PP2Ac) in regulating glioma immunogenicity. Genetic ablation of PP2Ac in glioma cells enhanced double stranded DNA (dsDNA) production and cGAS-type I interferon (IFN) signaling, MHC-I expression, and tumor mutational burden. In co-culture experiments, PP2Ac deficiency in glioma cells promoted dendritic cell (DC) cross presentation and clonal expansion of CD8+ T cells. In vivo, PP2Ac depletion sensitized tumors to immune checkpoint blockade and radiotherapy treatment. Single cell analysis demonstrated that PP2Ac deficiency increased CD8+ T cell, NK cell, and DC accumulation and reduced immunosuppressive tumor associated macrophages. Furthermore, loss of PP2Ac increased IFN signaling in myeloid and tumor cells and reduced expression of a tumor gene signature associated with worse patient survival in TCGA. Collectively, this study establishes a novel role for PP2Ac in inhibiting dsDNA-cGAS-STING signaling to suppress anti-tumor immunity in glioma.

Year:

2024

Collaborators (15)

Ali Nabavizadeh

University of Pennsylvania

UNITED STATES
View details

Elizabeth George

University of California, San Francisco

UNITED STATES
View details

Noriyuki Kasahara

Professor

University of California, San Francisco

UNITED STATES
View details

Annette M. Molinaro

University of California

UNITED STATES
View details

Mohamed Abdelbaki

Washington University

UNITED STATES
View details

Sabine Mueller

Adjunt Associate Professor

University of California

UNITED STATES
View details

Jinan Behnan

Assist.Prof

Karolinska Institutet

SWEDEN
View details

Nalin Gupta

Professor

University of California, San Francisco

UNITED STATES
View details

Erin Crotty

Assistant Professor/Principal Investigator

Seattle Children's Hospital

UNITED STATES
View details

Bohyeon Yu

University of California, San Francisco

UNITED STATES
View details

Beisi Xu

Principal Bioinformatics Research Scientist

St. Jude Children's Research Hospital

UNITED STATES
View details

Michael Prados

University of California

UNITED STATES
View details

Zhipeng Meng

Assistant Professor

University of Miami Miller School of Medicine

UNITED STATES
View details

Joanna J. Phillips

Profesor

University of California, San Francisco

UNITED STATES
View details

Winson S. Ho

Associate Professor

University of California

UNITED STATES
View details